-
1.
Ansarin K, Tolouian R, Ardalan M, Taghizadieh A, Varshochi M, Teimouri S, et al. Effect of bromhexine on clinical outcomes and mortality in COVID-19 patients: A randomized clinical trial. Bioimpacts. 2020;10(4):209-15. eng. doi: 10.34172/bi.2020.27. [PubMed: 32983936]. [PubMed Central: PMC7502909].
-
2.
Entrenas Castillo M, Entrenas Costa LM, Vaquero Barrios JM, Alcalá Díaz JF, López Miranda J, Bouillon R, et al. "Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study". J Steroid Biochem Mol Biol. 2020;203:105751. eng. doi: 10.1016/j.jsbmb.2020.105751. [PubMed: 32871238]. [PubMed Central: PMC7456194].
-
3.
Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2021;19(3):141-54. eng. doi: 10.1038/s41579-020-00459-7. [PubMed: 33024307]. [PubMed Central: PMC7537588].
-
4.
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-13. eng. doi: 10.1016/s0140-6736(20)30211-7. [PubMed: 32007143]. [PubMed Central: PMC7135076].
-
5.
World Health Organization. World Health Organization coronavirus disease (COVID-19) dashboard. 2020, [cited November 23, 2020]. Available from: https://covid19.who.int/.
-
6.
Kucharski AJ, Klepac P, Conlan AJK, Kissler SM, Tang ML, Fry H, et al. Effectiveness of isolation, testing, contact tracing, and physical distancing on reducing transmission of SARS-CoV-2 in different settings: a mathematical modelling study. Lancet Infect Dis. 2020;20(10):1151-60. eng. doi: 10.1016/s1473-3099(20)30457-6. [PubMed: 32559451]. [PubMed Central: PMC7511527].
-
7.
Reddy KP, Shebl FM, Foote JHA, Harling G, Scott JA, Panella C, et al. Cost-effectiveness of public health strategies for COVID-19 epidemic control in South Africa: a microsimulation modelling study. Lancet Glob Health. 2021;9(2):e120-9. eng. doi: 10.1016/s2214-109x(20)30452-6. [PubMed: 33188729]. [PubMed Central: PMC7834260].
-
8.
Vijayvargiya P, Garrigos ZE, Almeida NEC, Gurram PR, Stevens RW, Razonable RR. Treatment considerations for COVID-19: a critical review of the evidence (or lack thereof). Mayo Clin Proc. Elsevier; 2020. p. 1454-66.
-
9.
Luo H, Tang QL, Shang YX, Liang SB, Yang M, Robinson N, et al. Can Chinese Medicine Be Used for Prevention of Corona Virus Disease 2019 (COVID-19)? A Review of Historical Classics, Research Evidence and Current Prevention Programs. Chin J Integr Med. 2020;26(4):243-50. eng. doi: 10.1007/s11655-020-3192-6. [PubMed: 32065348]. [PubMed Central: PMC7088641].
-
10.
Ang L, Lee HW, Choi JY, Zhang J, Soo Lee M. Herbal medicine and pattern identification for treating COVID-19: a rapid review of guidelines. Integr Med Res. 2020;9(2):100407. eng. doi: 10.1016/j.imr.2020.100407. [PubMed: 32289016]. [PubMed Central: PMC7104236].
-
11.
Zhang DH, Wu KL, Zhang X, Deng SQ, Peng B. In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus. J Integr Med. 2020;18(2):152-8. eng. doi: 10.1016/j.joim.2020.02.005. [PubMed: 32113846]. [PubMed Central: PMC7102521].
-
12.
Ni L, Chen L, Huang X, Han C, Xu J, Zhang H, et al. Combating COVID-19 with integrated traditional Chinese and Western medicine in China. Acta Pharm Sin B. 2020;10(7):1149-62. eng. doi: 10.1016/j.apsb.2020.06.009. [PubMed: 32834946]. [PubMed Central: PMC7319939].
-
13.
Chen X, Wu Y, Chen C, Gu Y, Zhu C, Wang S, et al. Identifying potential anti-COVID-19 pharmacological components of traditional Chinese medicine Lianhuaqingwen capsule based on human exposure and ACE2 biochromatography screening. Acta Pharm Sin B. 2021;11(1):222-36. eng. doi: 10.1016/j.apsb.2020.10.002. [PubMed: 33072499]. [PubMed Central: PMC7547831].
-
14.
Patel MR, Patel RB, Thakore SD. Nanoemulsion in drug delivery. Applications of nanocomposite materials in drug delivery. Elsevier; 2018. p. 667-700.
-
15.
Mohammadzadeh R, Baradaran B, Yousefi B, Valizadeh H, Zakeri-Milani P. Attenuation of intestinal efflux pump thru polymers and preservatives. J Res Pharm. 2019;23(4):632-41.
-
16.
Lin LT, Hsu WC, Lin CC. Antiviral natural products and herbal medicines. J Tradit Complement Med. 2014;4(1):24-35. eng. doi: 10.4103/2225-4110.124335. [PubMed: 24872930]. [PubMed Central: PMC4032839].
-
17.
Bakhtiar L, Nasr SH. Canon of Medicine 5 Volume Set. Kazi Publications, Incorporated; 2014.
-
18.
Heber D. PDR for herbal medicines. Thomson PDR; 2004.
-
19.
Evans WC. Trease and Evans Pharmacognosy. Toronto: Saunders; 2002.
-
20.
Jami MSI, Sultana Z, Ali ME, Begum MM, Haque MM. Evaluation of analgesic and anti-inflammatory activities on ethanolic extract of Terminalia chebula fruits in experimental animal models. Am J Plant Sci. 2014;5:63-9.
-
21.
Belapurkar P, Goyal P, Tiwari-Barua P. Immunomodulatory effects of triphala and its individual constituents: a review. Indian J Pharm Sci. 2014;76(6):467-75. eng. [PubMed: 25593379]. [PubMed Central: PMC4293677].
-
22.
Shivaprasad HN, Kharya MD, Rana AC, Mohan S. Preliminary Immunomodulatory Activities of the Aqueous Extract of Terminalia chebula. Pharm Biol. 2006;44(1):32-4.
-
23.
Upadhyay S, Tripathi PK, Singh M, Raghavendhar S, Bhardwaj M, Patel AK. Evaluation of medicinal herbs as a potential therapeutic option against SARS-CoV-2 targeting its main protease. Phytother Res. 2020;34(12):3411-9. eng. doi: 10.1002/ptr.6802. [PubMed: 32748969]. [PubMed Central: PMC7436756].
-
24.
Sharma R, Prajapati GK, Akhoury G. Pentagalloylglucose, a phytochemical from Terminalia chebula can efficiently prevent SARS-CoV-2 entry: In Silico study. Isr J Plant Sci. 2021;1(aop):1-9.
-
25.
Baltina LA, Zarubaev VV, Baltina LA, Orshanskaya IA, Fairushina AI, Kiselev OI, et al. Glycyrrhizic acid derivatives as influenza A/H1N1 virus inhibitors. Bioorg Med Chem Lett. 2015;25(8):1742-6. eng. doi: 10.1016/j.bmcl.2015.02.074. [PubMed: 25801933]. [PubMed Central: PMC7127794].
-
26.
Wolkerstorfer A, Kurz H, Bachhofner N, Szolar OH. Glycyrrhizin inhibits influenza A virus uptake into the cell. Antiviral Res. 2009;83(2):171-8. eng. doi: 10.1016/j.antiviral.2009.04.012. [PubMed: 19416738]. [PubMed Central: PMC7126985].
-
27.
Yang R, Yuan BC, Ma YS, Zhou S, Liu Y. The anti-inflammatory activity of licorice, a widely used Chinese herb. Pharm Biol. 2017;55(1):5-18. eng. doi: 10.1080/13880209.2016.1225775. [PubMed: 27650551]. [PubMed Central: PMC7012004].
-
28.
Frattaruolo L, Carullo G, Brindisi M, Mazzotta S, Bellissimo L, Rago V, et al. Antioxidant and Anti-Inflammatory Activities of Flavanones from Glycyrrhiza glabra L. (licorice) Leaf Phytocomplexes: Identification of Licoflavanone as a Modulator of NF-kB/MAPK Pathway. Antioxidants (Basel). 2019;8(6). eng. doi: 10.3390/antiox8060186. [PubMed: 31226797]. [PubMed Central: PMC6616548].
-
29.
Ayeka PA, Bian Y, Githaiga PM, Zhao Y. The immunomodulatory activities of licorice polysaccharides (Glycyrrhiza uralensis Fisch.) in CT 26 tumor-bearing mice. BMC Complement Altern Med. 2017;17(1):536. eng. doi: 10.1186/s12906-017-2030-7. [PubMed: 29246138]. [PubMed Central: PMC5732493].
-
30.
Mazumder PM, Pattnayak S, Parvani H, Sasmal D, Rathinavelusamy P. Evaluation of immunomodulatory activity of Glycyrhiza glabra L roots in combination with zing. Asian Pac J Trop Biomed. 2012;2(1):S15-20.
-
31.
Abtahifroushani SM, EsmaeiliGouvarchinGhaleh H, Rezapor R, MansoriMotlagh B, Rostaei A. Immunomodulatory Effects by Hydroalcoholic Liquorice Root Extracts. J Adv Med Biomed Res. 2014;22(95):112-21.
-
32.
Cinatl J, Morgenstern B, Bauer G, Chandra P, Rabenau H, Doerr HW. Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet. 2003;361(9374):2045-6. eng. doi: 10.1016/s0140-6736(03)13615-x. [PubMed: 12814717]. [PubMed Central: PMC7112442].
-
33.
Ashfaq UA, Masoud MS, Nawaz Z, Riazuddin S. Glycyrrhizin as antiviral agent against Hepatitis C Virus. J Transl Med. 2011;9:112. eng. doi: 10.1186/1479-5876-9-112. [PubMed: 21762538]. [PubMed Central: PMC3169469].
-
34.
Sabouri Ghannad M, Mohammadi A, Safiallahy S, Faradmal J, Azizi M, Ahmadvand Z. The Effect of Aqueous Extract of Glycyrrhiza glabra on Herpes Simplex Virus 1. Jundishapur J Microbiol. 2014;7(7). eng. e11616. doi: 10.5812/jjm.11616. [PubMed: 25368801]. [PubMed Central: PMC4216581].
-
35.
Mouhajir F, Hudson JB, Rejdali M, Towers GHN. Multiple antiviral activities of endemic medicinal plants used by Berber peoples of Morocco. Pharm Biol. 2001;39(5):364-74.
-
36.
Jawhari FZ, El Moussaoui A, Bourhia M, Imtara H, Mechchate H, Es-Safi I, et al. Anacyclus pyrethrum (L): Chemical Composition, Analgesic, Anti-Inflammatory, and Wound Healing Properties. Molecules. 2020;25(22). eng. doi: 10.3390/molecules25225469. [PubMed: 33238392]. [PubMed Central: PMC7700217].
-
37.
Sharma V, Thakur M, Chauhan NS, Dixit VK. Immunomodulatory activity of petroleum ether extract of Anacyclus pyrethrum. Pharm Biol. 2010;48(11):1247-54. eng. doi: 10.3109/13880201003730642. [PubMed: 20843161].
-
38.
Manouze H, Bouchatta O, Gadhi AC, Bennis M, Sokar Z, Ba-M'hamed S. Anti-inflammatory, Antinociceptive, and Antioxidant Activities of Methanol and Aqueous Extracts of Anacyclus pyrethrum Roots. Front Pharmacol. 2017;8:598. eng. doi: 10.3389/fphar.2017.00598. [PubMed: 28928658]. [PubMed Central: PMC5591861].
-
39.
Vincent S, Arokiyaraj S, Saravanan M, Dhanraj M. Molecular Docking Studies on the Anti-viral Effects of Compounds From Kabasura Kudineer on SARS-CoV-2 3CL(pro). Front Mol Biosci. 2020;7:613401. eng. doi: 10.3389/fmolb.2020.613401. [PubMed: 33425994]. [PubMed Central: PMC7785853].
-
40.
Prasad A, Muthamilarasan M, Prasad M. Synergistic antiviral effects against SARS-CoV-2 by plant-based molecules. Plant Cell Rep. 2020;39(9):1109-14. eng. doi: 10.1007/s00299-020-02560-w. [PubMed: 32561979]. [PubMed Central: PMC7303273].
-
41.
Silva O, Barbosa S, Diniz A, Valdeira ML, Gomes E. Plant extracts antiviral activity against Herpes simplex virus type 1 and African swine fever virus. Int J Pharmacogn. 1997;35(1):12-6.
-
42.
Guarize L, Costa JC, Dutra LB, Mendes RF, Lima IV, Scio E. Anti-inflammatory, laxative and intestinal motility effects of Senna macranthera leaves. Nat Prod Res. 2012;26(4):331-43. eng. doi: 10.1080/14786411003754264. [PubMed: 21432718].
-
43.
Farid A, Kamel D, Abdelwahab Montaser S, Mohamed Ahmed M, El Amir M, El Amir A. Synergetic role of senna and fennel extracts as antioxidant, anti-inflammatory and anti-mutagenic agents in irradiated human blood lymphocyte cultures. J Radiat Res Appl Sci. 2020;13(1):191-9.
-
44.
Zhang WJ, Wang S, Kang CZ, Lv CG, Zhou L, Huang LQ, et al. Pharmacodynamic material basis of traditional Chinese medicine based on biomacromolecules: a review. Plant Methods. 2020;16:26. eng. doi: 10.1186/s13007-020-00571-y. [PubMed: 32140174]. [PubMed Central: PMC7049221].
-
45.
Balaban YH, Aka C, Koca-Caliskan U. Liver immunology and herbal treatment. World J Hepatol. 2017;9(17):757-70. eng. doi: 10.4254/wjh.v9.i17.757. [PubMed: 28660010]. [PubMed Central: PMC5474722].
-
46.
Kumar S, Naeem R, Radhawi AST, Mahmood SU, Batool Z, Naqi SRA. Senna Makki and the COVID-19 pandemic: a reflection from Pakistan. Int J Community Med Public Health. 2020;7(12):5194.
-
47.
Ghannadi A, Fattahian K, Shokoohinia Y, Behbahani M, Shahnoush A. Anti-Viral Evaluation of Sesquiterpene Coumarins from Ferula assa-foetida against HSV-1. Iran J Pharm Res. 2014;13(2):523-30. eng. [PubMed: 25237347]. [PubMed Central: PMC4157027].
-
48.
Bagheri SM, Hedesh ST, Mirjalili A, Dashti R. Evaluation of Anti-inflammatory and Some Possible Mechanisms of Antinociceptive Effect of Ferula assa foetida Oleo Gum Resin. J Evid Based Complementary Altern Med. 2016;21(4):271-6. eng. doi: 10.1177/2156587215605903. [PubMed: 26427790].
-
49.
Bagheri SM, Dashti R, Morshedi A. Antinociceptive effect of Ferula assa-foetida oleo-gum-resin in mice. Res Pharm Sci. 2014;9(3):207-12. eng. [PubMed: 25657791]. [PubMed Central: PMC4311286].
-
50.
Amalraj A, Gopi S. Biological activities and medicinal properties of Asafoetida: A review. J Tradit Complement Med. 2017;7(3):347-59. eng. doi: 10.1016/j.jtcme.2016.11.004. [PubMed: 28725631]. [PubMed Central: PMC5506628].
-
51.
Safari O, Sarkheil M, Paolucci M. Dietary administration of ferula (Ferula asafoetida) powder as a feed additive in diet of koi carp, Cyprinus carpio koi: effects on hemato-immunological parameters, mucosal antibacterial activity, digestive enzymes, and growth performance. Fish Physiol Biochem. 2019;45(4):1277-88. eng. doi: 10.1007/s10695-019-00674-x. [PubMed: 31256305].
-
52.
Natesh J, Mondal P, Penta D, Abdul Salam AA, Meeran SM. Culinary spice bioactives as potential therapeutics against SARS-CoV-2: Computational investigation. Comput Biol Med. 2021;128:104102. eng. doi: 10.1016/j.compbiomed.2020.104102. [PubMed: 33190011]. [PubMed Central: PMC7606080].
-
53.
Jin F, Ma K, Chen M, Zou M, Wu Y, Li F, et al. Pentagalloylglucose Blocks the Nuclear Transport and the Process of Nucleocapsid Egress to Inhibit HSV-1 Infection. Jpn J Infect Dis. 2016;69(2):135-42. eng. doi: 10.7883/yoken.JJID.2015.137. [PubMed: 26166506].
-
54.
Pei Y, Chen ZP, Ju HQ, Komatsu M, Ji YH, Liu G, et al. Autophagy is involved in anti-viral activity of pentagalloylglucose (PGG) against Herpes simplex virus type 1 infection in vitro. Biochem Biophys Res Commun. 2011;405(2):186-91. eng. doi: 10.1016/j.bbrc.2011.01.006. [PubMed: 21216235].
-
55.
Maxia A, Sanna C, Frau MA, Piras A, Karchuli MS, Kasture V. Anti-inflammatory activity of Pistacia lentiscus essential oil: involvement of IL-6 and TNF-alpha. Nat Prod Commun. 2011;6(10):1543-4. eng. [PubMed: 22164803].
-
56.
Dellai A, Souissi H, Borgi W, Bouraoui A, Chouchane N. Antiinflammatory and antiulcerogenic activities of Pistacia lentiscus L. leaves extracts. Ind Crops Prod. 2013;49:879-82.
-
57.
Kottakis F, Kouzi-Koliakou K, Pendas S, Kountouras J, Choli-Papadopoulou T. Effects of mastic gum Pistacia lentiscus var. Chia on innate cellular immune effectors. Eur J Gastroenterol Hepatol. 2009;21(2):143-9. eng. doi: 10.1097/MEG.0b013e32831c50c9. [PubMed: 19212203].
-
58.
Gacem MA, El Hadj-Khelil AO, Boudjemaa B, Gacem H. Phytochemistry, Toxicity and Pharmacology of Pistacia lentiscus, Artemisia herba-alba and Citrullus colocynthis. Sustain Agr Rev. 2020;39:57-93.
-
59.
Shiri AH, Rayatdoost E, Afkhami H, Ravanshad R, Hosseini SE, Kalani N, et al. The herbal combination of Sugarcane, Black Myrobalan, and mastic as a supplementary treatment for COVID-19: a randomized clinical trial. medRxiv. 2021.
-
60.
Benzekri R, Limam F, Bouslama L. Combination effect of three anti-HSV-2 active plant extracts exhibiting different modes of action. Orient Pharm Exp Med. 2020;20(2):223-31.
-
61.
Hong EH, Song JH, Kang KB, Sung SH, Ko HJ, Yang H. Anti-Influenza Activity of Betulinic Acid from Zizyphus jujuba on Influenza A/PR/8 Virus. Biomol Ther (Seoul). 2015;23(4):345-9. eng. doi: 10.4062/biomolther.2015.019. [PubMed: 26157551]. [PubMed Central: PMC4489829].
-
62.
Al-Reza SM, Yoon JI, Kim HJ, Kim JS, Kang SC. Anti-inflammatory activity of seed essential oil from Zizyphus jujuba. Food Chem Toxicol. 2010;48(2):639-43. eng. doi: 10.1016/j.fct.2009.11.045. [PubMed: 19944733].
-
63.
Mesaik AM, Poh HW, Bin OY, Elawad I, Alsayed B. In Vivo Anti-Inflammatory, Anti-Bacterial and Anti-Diarrhoeal Activity of Ziziphus Jujuba Fruit Extract. Open Access Maced J Med Sci. 2018;6(5):757-66. eng. doi: 10.3889/oamjms.2018.168. [PubMed: 29875842]. [PubMed Central: PMC5985874].
-
64.
Yu ZP, Xu DD, Lu LF, Zheng XD, Chen W. Immunomodulatory effect of a formula developed from American ginseng and Chinese jujube extracts in mice. J Zhejiang Univ Sci B. 2016;17(2):147-57. eng. doi: 10.1631/jzus.B1500170. [PubMed: 26834015]. [PubMed Central: PMC4757584].
-
65.
Ji X, Liu F, Ullah N, Wang M. Isolation, purification, and antioxidant activities of polysaccharides from Ziziphus Jujuba cv. Muzao. Int J Food Prop. 2018;21(1):1-11.
-
66.
Verma S, Twilley D, Esmear T, Oosthuizen CB, Reid AM, Nel M, et al. Anti-SARS-CoV Natural Products With the Potential to Inhibit SARS-CoV-2 (COVID-19). Front Pharmacol. 2020;11:561334. eng. doi: 10.3389/fphar.2020.561334. [PubMed: 33101023]. [PubMed Central: PMC7546787].
-
67.
Bahramsoltani R, Rahimi R. An Evaluation of Traditional Persian Medicine for the Management of SARS-CoV-2. Front Pharmacol. 2020;11:571434. eng. doi: 10.3389/fphar.2020.571434. [PubMed: 33324206]. [PubMed Central: PMC7724033].
-
68.
Khavari A, Bolhassani A, Alizadeh F, Bathaie SZ, Balaram P, Agi E, et al. Chemo-immunotherapy using saffron and its ingredients followed by E7-NT (gp96) DNA vaccine generates different anti-tumor effects against tumors expressing the E7 protein of human papillomavirus. Arch Virol. 2015;160(2):499-508. eng. doi: 10.1007/s00705-014-2250-9. [PubMed: 25395243].
-
69.
Zeinali M, Zirak MR, Rezaee SA, Karimi G, Hosseinzadeh H. Immunoregulatory and anti-inflammatory properties of Crocus sativus (Saffron) and its main active constituents: A review. Iran J Basic Med Sci. 2019;22(4):334-44. eng. doi: 10.22038/ijbms.2019.34365.8158. [PubMed: 31223464]. [PubMed Central: PMC6535192].
-
70.
Hosseinzadeh H, Younesi HM. Antinociceptive and anti-inflammatory effects of Crocus sativus L. stigma and petal extracts in mice. BMC Pharmacol. 2002;2:7. eng. doi: 10.1186/1471-2210-2-7. [PubMed: 11914135]. [PubMed Central: PMC101384].
-
71.
Husaini AM, Jan KN, Wani GA. Saffron: A potential drug-supplement for severe acute respiratory syndrome coronavirus (COVID) management. Heliyon. 2021;7(5). eng. e07068. doi: 10.1016/j.heliyon.2021.e07068. [PubMed: 34007917]. [PubMed Central: PMC8118646].
-
72.
Turner RB, Bauer R, Woelkart K, Hulsey TC, Gangemi JD. An evaluation of Echinacea angustifolia in experimental rhinovirus infections. N Engl J Med. 2005;353(4):341-8. eng. doi: 10.1056/NEJMoa044441. [PubMed: 16049208].
-
73.
Tragni E, Galli CL, Tubaro A, Del Negro P, Della Loggia R. Anti-inflammatory activity of Echinacea angustifolia fractions separated on the basis of molecular weight. Pharmacol Res Commun. 1988;20 Suppl 5:87-90. eng. doi: 10.1016/s0031-6989(88)80848-8. [PubMed: 3247359].
-
74.
Catanzaro M, Corsini E, Rosini M, Racchi M, Lanni C. Immunomodulators Inspired by Nature: A Review on Curcumin and Echinacea. Molecules. 2018;23(11). eng. doi: 10.3390/molecules23112778. [PubMed: 30373170]. [PubMed Central: PMC6278270].
-
75.
Bajrai LH, El-Kafrawy SA, Alnahas RS, Azhar EI. In vitro screening of anti-viral and virucidal effects against SARS-CoV-2 by Hypericum perforatum and Echinacea. bioRxiv. 2021.
-
76.
Kreis W, Kaplan MH, Freeman J, Sun DK, Sarin PS. Inhibition of HIV replication by Hyssop officinalis extracts. Antiviral Res. 1990;14(6):323-37. eng. doi: 10.1016/0166-3542(90)90051-8. [PubMed: 1708226].
-
77.
Wang HY, Ding JB, Halmurat U, Hou M, Xue ZQ, Zhu M, et al. The effect of Uygur medicine Hyssopus officinalis L on expression of T-bet, GATA-3 and STAT-3 mRNA in lung tissue of asthma rats. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2011;27(8):876-9.
-
78.
Soleimani H, Barzegar M, Sahari MA, Naghdi Badi H. An investigation on the antioxidant activities of Hyssopus officinalis L. and Echinacea purpurea L. plant extracts in oil model system. J Med Plants. 2011;10(37):61-72.
-
79.
Babich O, Sukhikh S, Prosekov A, Asyakina L, Ivanova S. Medicinal Plants to Strengthen Immunity during a Pandemic. Pharmaceuticals (Basel). 2020;13(10). eng. doi: 10.3390/ph13100313. [PubMed: 33076514]. [PubMed Central: PMC7602650].
-
80.
WHO. Quality control methods of medicinal plant material. Geneva; 1998. 24 p.
LEAVE A COMMENT HERE: